Janssen and Mundipharma sign distribution deal for type 2 diabetes treatments

Janssen Pharmaceutica has entered an exclusive distribution agreement with Mundipharma Medical Company for Invokana (canagliflozin) and Vokanamet (a fixed-dose combination therapy of canagliflozin and metformin) to treat patients with type 2 diabetes …
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news